Cosan (CSAN3) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Jul, 2026Executive summary
EBITDA under management reached R$7.1 billion, up 15% year-over-year, driven by higher volumes, improved margins, and strong segment results across key businesses.
Net loss at the corporate level was R$227 million, a significant improvement from -R$1.0 billion in 2Q23, reflecting higher equity pickup and lower financial expenses.
Dividend and interest on capital receipts totaled R$2.1 billion, up sharply from R$267 million in 2Q23.
Management remains focused on capital discipline, operational execution, and safety standards amid macroeconomic volatility and higher interest rates.
Major events included Moove's IPO process, Compass's acquisition of Compagas, and Rumo's investment optimization at Santos Port.
Financial highlights
Net debt at the corporate level decreased to R$21.3 billion from R$22.7 billion in 1Q24; DSCR improved to 1.3x from 1.1x year-over-year.
Cash balance rose to R$4 billion, with R$1.4 billion earmarked for liability management.
Net financial expense improved by R$661 million year-over-year, mainly due to gains from unwinding collar financing and lower MtM losses.
Gross profit for 2Q24 was R$3.6 billion, up from R$2.8 billion in 2Q23.
Net financial expenses for 6M24 totaled R$4.3 billion, reflecting higher debt costs and negative derivative results.
Outlook and guidance
Management expects continued disciplined capital allocation, leverage control, and support for contracted growth projects, with investments aligned to the strategic roadmap.
No major changes expected in the portfolio mix or Vale stake in the short term.
Targeting a sustainable debt service coverage ratio of 1.5x, aiming for stability by end of 2025.
Latest events from Cosan
- EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 20259 Jul 2026 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 20258 Jul 2026 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 20242 Jul 2026 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 20242 Jul 2026 - Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 202622 May 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 20253 Feb 2026